1 September 2020 - Advantages in health related quality of life, symptoms and side effects outweigh disadvantages. ...
17 August 2020 - New data from the PROSPER study shows benefit in overall survival. ...
3 August 2020 - Advantages in overall survival, symptoms and health-related quality of life. ...
17 July 2020 - Dossiers submitted for early benefit assessments in Germany also provide information on the precise determination of the ...
10 July 2020 - After Germany revamped its approach to purchasing medicines a decade ago, the prices negotiated by the ...
7 July 2020 - Worldwide spending on prescription drugs has increased dramatically in recent years. Although this increase has been particularly ...
2 June 2020 - Re-valuations after the expiry of the time limit new data cuts confirm advantages and disadvantages ...
15 January 2020 - First assessment of a histology-independent drug/studies without control arms. ...
1 August 2019 - Prolonged survival is sometimes accompanied by severe side effects, symptom and quality of life deterioration ...
10 July 2019 - On 20 June 2019, for the first time, the German Federal Joint Committee (G-BA), made the resolution ...
15 May 2019 - There are no serious disadvantages in terms of overall survival. ...
15 April 2019 - In the overall view, an added benefit is not proven. ...
15 January 2019 - Only a few study participants were treated in compliance with the approval, therefore the extent of ...
1 October 2018 - Effect on disease-free survival too small to conclude on overall survival. ...
21 June 2018 - The early benefit assessment of pharmaceuticals in Germany and their preceding market authorisation pursue different objectives. ...